Saturday, March 29, 2014

[Articles] Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

[Articles] Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
The Lancet Neurology

Our findings show that suvorexant was generally safe and well tolerated over 1 year of nightly treatment in patients with insomnia, with efficacy noted for subjective measures of sleep onset and maintenance.

Original Article: http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70053-5/abstract?rss=yes

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)